Clathrin mediates infectious hepatitis C virus particle egress

Journal of Virology

Volumn 89, Issue 8, 2015, Pages 4180-4190

  Benedicto, Ignacio ^a,b,e   Gondar, Virgínia ^a,b   Molina Jiménez, Francisca ^a   García Buey, Luisa ^a,b   López Cabrera, Manuel ^c   Gastaminza, Pablo ^d   Majano, Pedro L ^a,b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CLATHRIN; DYNAMIN; LIPID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; EXOCYTOSIS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIPID HOMEOSTASIS; LIPID METABOLISM; LIVER CELL; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS RELEASE; BIOLOGICAL MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; GENETICS; HEPACIVIRUS; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; SERODIAGNOSIS; TUMOR CELL LINE; WESTERN BLOTTING;

HEPATITIS C VIRUS;

APOLIPOPROTEINS E; BLOTTING, WESTERN; CELL LINE, TUMOR; CLATHRIN; ENDOPLASMIC RETICULUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOPRECIPITATION; MODELS, BIOLOGICAL; NEUTRALIZATION TESTS; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTOR AP-1; VIRUS RELEASE;

EID: 84925433465     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03620-14     Document Type: Article

References (42)

1. Bartenschlager R, Penin F, Lohmann V, Andre P. 2011. Assembly of infectious hepatitis C virus particles. Trends Microbiol 19:95-103. http://dx.doi.org/10.1016/j.tim.2010.11.005.
2. Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL. 2006. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80: 2418-2428. http://dx.doi.org/10.1128/JVI.80.5.2418-2428.2006.
3. Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, Funami K, Ohsaki Y, Fujimoto T, Takaku H, Wakita T, Baumert TF, Miyanari Y, Shimotohno K. 2010. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 84:12048-12057. http://dx.doi.org/10.1128/JVI.01063-10.
4. Owen DM, Huang H, Ye J, Gale M, Jr. 2009. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with lowdensity lipoprotein receptor. Virology 394:99-108. http://dx.doi.org/10.1016/j.virol.2009.08.037.
5. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV. 2008. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 82:2120-2129. http://dx.doi.org/10.1128/JVI.02053-07.
6. Jiang J, Luo G. 2009. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol 83:12680-12691. http://dx.doi.org/10.1128/JVI.01476-09.
7. Lai CK, Jeng KS, Machida K, Lai MM. 2010. Hepatitis C virus egress and release depend on endosomal trafficking of core protein. J Virol 84: 11590-11598. http://dx.doi.org/10.1128/JVI.00587-10.
8. Coller KE, Heaton NS, Berger KL, Cooper JD, Saunders JL, Randall G. 2012. Molecular determinants and dynamics of hepatitis C virus secretion. PLoS Pathog 8:e1002466. http://dx.doi.org/10.1371/journal.ppat.1002466.
9. Brodsky FM. 2012. Diversity of clathrin function: new tricks for an old protein. Annu Rev Cell Dev Biol 28:309-336. http://dx.doi.org/10.1146/annurev-cellbio-101011-155716.
10. Robinson MS. 2004. Adaptable adaptors for coated vesicles. Trends Cell Biol 14:167-174. http://dx.doi.org/10.1016/j.tcb.2004.02.002.
11. Humphries AC, Dodding MP, Barry DJ, Collinson LM, Durkin CH, Way M. 2012. Clathrin potentiates vaccinia-induced actin polymerization to facilitate viral spread. Cell Host Microbe 12:346-359. http://dx.doi.org/10.1016/j.chom.2012.08.002.
12. Huang C, Chang SC, Yang HC, Chien CL, Chang MF. 2009. Clathrinmediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus. J Virol 83:12314-12324. http://dx.doi.org/10.1128/JVI.01044-09.
13. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu Rev Biochem 79:803-833. http://dx.doi.org/10.1146/annurev-biochem-060208-104626.
14. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, Rouille Y. 2006. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80:6964-6972. http://dx.doi.org/10.1128/JVI.00024-06.
15. Meertens L, Bertaux C, Dragic T. 2006. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80:11571-11578. http://dx.doi.org/10.1128/JVI.01717-06.
16. Bitzegeio J, Bankwitz D, Hueging K, Haid S, Brohm C, Zeisel MB, Herrmann E, Iken M, Ott M, Baumert TF, Pietschmann T. 2010. Adaptation of hepatitisCvirus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog 6:e1000978. http://dx.doi.org/10.1371/journal.ppat.1000978.
17. Benedicto I, Molina-Jimenez F, Barreiro O, Maldonado-Rodriguez A, Prieto J, Moreno-Otero R, Aldabe R, Lopez-Cabrera M, Majano PL. 2008. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 48:1044-1053. http://dx.doi.org/10.1002/hep.22465.
18. Molina-Jimenez F, Benedicto I, Dao Thi VL, Gondar V, Lavillette D, Marin JJ, Briz O, Moreno-Otero R, Aldabe R, Baumert TF, Cosset FL, Lopez-Cabrera M, Majano PL. 2012. Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology 425:31-39. http://dx.doi.org/10.1016/j.virol.2011.12.021.
19. von Kleist L, Stahlschmidt W, Bulut H, Gromova K, Puchkov D, Robertson MJ, MacGregor KA, Tomilin N, Pechstein A, Chau N, Chircop M, Sakoff J, von Kries JP, Saenger W, Krausslich HG, Shupliakov O, Robinson PJ, McCluskey A, Haucke V. 2011. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146:471-484. http://dx.doi.org/10.1016/j.cell.2011.06.025.
20. Liu S, Kuo W, Yang W, Liu W, Gibson GA, Dorko K, Watkins SC, Strom SC, Wang T. 2010. The second extracellular loop dictates occludin-mediated HCV entry. Virology 407:160-170. http://dx.doi.org/10.1016/j.virol.2010.08.009.
21. Gastaminza P, Kapadia SB, Chisari FV. 2006. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 80:11074-11081. http://dx.doi.org/10.1128/JVI.01150-06.
22. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232. http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x.
23. Ferguson SM, De Camilli P. 2012. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 13:75-88. http://dx.doi.org/10.1038/nrm3266.
24. Bonazzi M, Spano S, Turacchio G, Cericola C, Valente C, Colanzi A, Kweon HS, Hsu VW, Polishchuck EV, Polishchuck RS, Sallese M, Pulvirenti T, Corda D, Luini A. 2005. CtBP3/BARS drives membrane fission in dynamin-independent transport pathways. Nat Cell Biol 7:570-580. http://dx.doi.org/10.1038/ncb1260.
25. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. 2006. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839-850. http://dx.doi.org/10.1016/j.devcel.2006.04.002.
26. Ehrlich M, Boll W, Van Oijen A, Hariharan R, Chandran K, Nibert ML, Kirchhausen T. 2004. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118:591-605. http://dx.doi.org/10.1016/j.cell.2004.08.017.
27. Boucrot E, Saffarian S, Zhang R, Kirchhausen T. 2010. Roles of AP-2 in clathrin-mediated endocytosis. PLoS One 5:e10597. http://dx.doi.org/10.1371/journal.pone.0010597.
28. Merz A, Long G, Hiet MS, Brugger B, Chlanda P, Andre P, Wieland F, Krijnse-Locker J, Bartenschlager R. 2011. Biochemical and morphological properties of hepatitisCvirus particles and determination of their lipidome. J Biol Chem 286:3018-3032. http://dx.doi.org/10.1074/jbc.M110.175018.
29. Nielsen SU, Bassendine MF, Martin C, Lowther D, Purcell PJ, King BJ, Neely D, Toms GL. 2008. Characterization of hepatitis C RNAcontaining particles from human liver by density and size. J Gen Virol 89:2507-2517. http://dx.doi.org/10.1099/vir.0.2008/000083-0.
30. Klausner RD, Donaldson JG, Lippincott-Schwartz J. 1992. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116:1071-1080. http://dx.doi.org/10.1083/jcb.116.5.1071.
31. Deborde S, Perret E, Gravotta D, Deora A, Salvarezza S, Schreiner R, Rodriguez-Boulan E. 2008. Clathrin is a key regulator of basolateral polarity. Nature 452:719-723. http://dx.doi.org/10.1038/nature06828.
32. Gan Y, McGraw TE, Rodriguez-Boulan E. 2002. The epithelial-specific adaptor AP1B mediates post-endocytic recycling to the basolateral membrane. Nat Cell Biol 4:605-609. http://dx.doi.org/10.1038/ncb827.
33. Gravotta D, Carvajal-Gonzalez JM, Mattera R, Deborde S, Banfelder JR, Bonifacino JS, Rodriguez-Boulan E. 2012. The clathrin adaptor AP-1A mediates basolateral polarity. Dev Cell 22:811-823. http://dx.doi.org/10.1016/j.devcel.2012.02.004.
34. Bishe B, Syed GH, Field SJ, Siddiqui A. 2012. Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. J Biol Chem 287:27637-27647. http://dx.doi.org/10.1074/jbc.M112.346569.
35. Lu X, Mehta A, Dadmarz M, Dwek R, Blumberg BS, Block TM. 1997. Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. Proc Natl Acad Sci U S A 94:2380-2385. http://dx.doi.org/10.1073/pnas.94.6.2380.
36. Tang Y, Leao IC, Coleman EM, Broughton RS, Hildreth JE. 2009. Deficiency of Niemann-Pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments. J Virol 83:7982-7995. http://dx.doi.org/10.1128/JVI.00259-09.
37. Neveu G, Barouch-Bentov R, Ziv-Av A, Gerber D, Jacob Y, Einav S. 2012. Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly. PLoS Pathog 8:e1002845. http://dx.doi.org/10.1371/journal.ppat.1002845.
38. Wernette-Hammond ME, Lauer SJ, Corsini A, Walker D, Taylor JM, Rall SC, Jr. 1989. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem 264:9094-9101.
39. Rodriguez-Boulan E, Kreitzer G, Musch A. 2005. Organization of vesicular trafficking in epithelia. Nat Rev Mol Cell Biol 6:233-247. http://dx.doi.org/10.1038/nrm1593.
40. Ivanovic T, Boulant S, Ehrlich M, Demidenko AA, Arnold MM, Kirchhausen T, Nibert ML. 2011. Recruitment of cellular clathrin to viral factories and disruption of clathrin-dependent trafficking. Traffic 12: 1179-1195. http://dx.doi.org/10.1111/j.1600-0854.2011.01233.x.
41. Mee CJ, Farquhar MJ, Harris HJ, Hu K, Ramma W, Ahmed A, Maurel P, Bicknell R, Balfe P, McKeating JA. 2010. Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factordependent manner. Gastroenterology 138:1134-1142. http://dx.doi.org/10.1053/j.gastro.2009.11.047.
42. Konan KV, Giddings TH, Jr, Ikeda M, Li K, Lemon SM, Kirkegaard K. 2003. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J Virol 77: 7843-7855. http://dx.doi.org/10.1128/JVI.77.14.7843-7855.2003.